Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.74 USD | -1.00% | +17.85% | -14.58% |
Apr. 02 | EyePoint Pharmaceuticals, Inc. Expands Scientific Advisory Board | CI |
Mar. 18 | EyePoint Pharmaceuticals, Inc.(NasdaqGM:EYPT) added to S&P Pharmaceuticals Select Industry Index | CI |
Financials (USD)
Sales 2024 * | 38.54M | Sales 2025 * | 11.7M | Capitalization | 1.03B |
---|---|---|---|---|---|
Net income 2024 * | -93M | Net income 2025 * | -156M | EV / Sales 2024 * | 21.1 x |
Net cash position 2024 * | 215M | Net cash position 2025 * | 348M | EV / Sales 2025 * | 58.1 x |
P/E ratio 2024 * |
-10.4
x | P/E ratio 2025 * |
-6.57
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.89% |
Latest transcript on EyePoint Pharmaceuticals, Inc.
1 day | -1.00% | ||
1 week | +17.85% | ||
Current month | +12.16% | ||
1 month | -2.03% | ||
3 months | -31.22% | ||
6 months | +154.71% | ||
Current year | -14.58% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
George Elston
DFI | Director of Finance/CFO | 59 | 19-11-13 |
Said Saim
CTO | Chief Tech/Sci/R&D Officer | 66 | 19-06-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
Wendy DiCicco
BRD | Director/Board Member | 56 | 19-07-14 |
David Guyer
BRD | Director/Board Member | 64 | 19-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 11 M€ | -6.03% | - | |
0.37% | 4 M€ | -5.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 19.74 | -1.00% | 928,801 |
24-05-02 | 19.94 | +10.53% | 2,112,381 |
24-05-01 | 18.04 | +2.50% | 728,483 |
24-04-30 | 17.6 | -0.17% | 957,489 |
24-04-29 | 17.63 | +5.25% | 793,310 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.58% | 1.03B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- EYPT Stock